Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | PPARG | P37231 | 6/20 | 0.52 |
| ▸ | PPARD | Q03181 | 5/20 | 0.52 |
| ▸ | PPARA | Q07869 | 5/20 | 0.52 |
| ▸ | TERT | O14746 | 3/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | BLM | P54132 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | FABP4 | P15090 | 3/20 | 0.52 |
| ▸ | TOP1 | P11387 | 3/20 | 0.52 |
| ▸ | USP2 | O75604 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | RECQL | P46063 | 2/20 | 0.52 |
| ▸ | F7 | P08709 | 2/20 | 0.52 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.52 |
| ▸ | F3 | P13726 | 2/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11301832 | 0.95 | CA2 (0.66) | CA2MAPK1PPARGPPARDPPARA | |
| SCHEMBL358162 | 0.95 | CA2 (0.66) | CA2MAPK1PPARGPPARDPPARA | |
| SCHEMBL1015155 | 0.95 | CA2 (0.66) | CA2MAPK1PPARGPPARDPPARA | |
| SCHEMBL358160 | 0.95 | CA2 (0.66) | CA2MAPK1PPARGPPARDPPARA | |
| SCHEMBL3022238 | 0.95 | CA2 (0.66) | CA2MAPK1PPARGPPARDPPARA | |
| SCHEMBL1116087 | 0.95 | CA2 (0.66) | CA2MAPK1PPARGPPARDPPARA | |
| SCHEMBL397443 | 0.95 | CA2 (0.66) | CA2MAPK1PPARGPPARDPPARA | |
| SCHEMBL11301839 | 0.95 | CA2 (0.66) | CA2MAPK1PPARGPPARDPPARA | |
| SCHEMBL26107677 | 0.93 | CA2 (0.62) | CA2MAPK1PPARGPPARDPPARA | |
| SCHEMBL11291007 | 0.93 | CA2 (0.68) | CA2MAPK1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250205362-A1 | LIPID NANOPARTICLES | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2025-06-26 | — | — | US | disclosed |
| CN-119698302-A | Lipid nanoparticles | 国立大学法人北海道大学 | 2025-03-25 | — | — | CN | disclosed |
| EP-4501359-A1 | LIPID NANOPARTICLES | National University Corporation Hokkaido University (JP) | 2025-02-05 | — | — | EP | disclosed |
| WO-2023188830-A1 | LIPID NANOPARTICLES | 国立大学法人北海道大学 | 2023-10-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250205362-A1 | LIPID NANOPARTICLES | ECH1, C1R, SGMS1 | CA2 784/4885MAPK1 2523/4885PPARG 3420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.